Post-Operative Pain Therapeutics Pipeline to Witness Many Technological Advancements in the Coming Years     |    Global Coding and Marking Market Witness 9.4% CAGR During 2017 – 2023     |    Global HIV Diagnosis Market to Witness 10.6% CAGR during 2017 – 2023
P&S Market Research - A market research firm

Automated External Defibrillator Market

P&S Market Research-Automated External Defibrillator Market report

Global Automated External Defibrillator (AED) Market Size, Share, Development, Growth and Demand Forecast to 2023

Delivery : 24-72 Working Hours
Report Code: LS10166
Available Format: pdf

Over the recent years, the global automated external defibrillator (AED) market has witnessed double digit growth, due to the rising frequencies of several cardio-vascular diseases and aging population. Rapid growth in the aging population with higher risk of target diseases is a major driver influencing the growth of automated external defibrillator market. Moreover, extensive availability of medical facilities for patients suffering from sudden cardiac arrest (SCA) and advancement in medical technology are some drivers of the global automated external defibrillator market. The automated external cardiac defibrillator market is one of the fastest growing segments whereas; the implantable/Internal cardiac defibrillators segment is one of the largest segments in the global defibrillator market.

The automated external defibrillator market can be classified on the basis of technology and end-user. On the basis of technology, the global automated external defibrillator market is further divided into semi-automated and fully automated external defibrillators. The end-user market for automated external defibrillator is categorized into hospitals, pre-hospitals, public access and other alternate care market.

An automated external defibrillator can identify and detect life threatening arrhythmias. One of the main cardiovascular disorders affecting worldwide population is the sudden cardiac arrest (SCA). In sudden cardiac arrest, the heartbeat suddenly stops and can result in death. SCA is a disorder in which the heart abruptly and unpredictably stops functioning or beating, which finally leads to the reduced blood supply to brain and many other vital organs of the body. About 95% of patients who suffer from sudden cardiac arrest die within a minute. This arrest occurs due to an irregular heart rhythm, which is known as ventricular fibrillation. The AED enables diagnosis of life risking cardiac arrests of ventricular fibrillation and ventricular tachycardia in patients and keeps a check on heart rhythm. AED works on the basis of electrical analysis, which stops the arrhythmia by establishing an effective rhythm.

However, sudden cardiac arrest is different from a heart attack. In a sudden cardiac arrest, when the heart stops beating, its electrical system is affected and blood flow to the brain interrupts the functioning of other organs. On the other hand, a heart attack happens, due to the blockage of blood vessels, which results in interruption of blood flow. Therefore, an automated external defibrillator provides an electric shock to restore the patient's normal cardiac rhythm.

A home use defibrillator has hit the market of automated external defibrillators and is anticipated to provide vast opportunities in the near future. The only automated external defibrillator approved for home use is, Philips HeartStart Home Defibrillator which works by delivering a jolt of electricity to the patient in case of irregular heartbeat. The growth of automated external defibrillators is due to increased awareness in the US healthcare system. Various opportunities arising from emerging markets of developing countries are expected to provide major boost to the global automated external defibrillator market.

However, lack of awareness about sudden cardiac arrest is a major factor restraining the growth of the global automated external defibrillator market.

Some of the major players in the global automated external defibrillator market include- Cardiac Science, Inc, Boston Scientific Corporation, Biotronik GmbH & Co. KG, Defibtech, LLC, NIHON KOHDEN CORPORATION, General Electric Company, St. Jude Medical, Inc., HeartSine Technologies Inc., Welch Allyn and Koninklijke Philips N.V.

 

Report Coverage

  • Provides comprehensive understanding of the market with the help of informed market outlook, opportunities, challenges, trends, size and growth, competitive analysis, major competitors and Porter analysis
  • Identifies the key drivers of growth and challenges of the key industry players. Also, assesses the future impact of the propellants and restraints on the market
  • Uncovers potential demands in the market
  • Porter analysis identifies competitive forces within the market
  • Provides information on the historical and current market size and the future potential of the market
  • Provides sizes of key regional markets using yardsticks of segments, applications, and segments of applications
  • Highlights the competitive scenario of the market, major competitors, and benchmarking
  • Provides profiles of major competitors of the market including details of their operations, product and services, recent developments and key financial metrics. Profiles provide better understanding of competition as well as the demands of the market.

Place An Order

Single User License

Single User License authorizes access of the publication to single user, i.e. the buyer of the report.

5100
Group License

Group License authorizes access of the publication upto 5 users.

6100
Enterprise License

Enterprise License provides right to distribute copies of the publication across the organization and its subsidiaries.

9100
down-arrow

Pre-Purchase Enquiry


 

Contact Us

  • U.S. Center : 347 5th Ave. #1402- 210 New York City, NY 10016 United States
  • Asian Center : B-28, Sector 1, Noida, U.P. - 201301 India.

Secure Online Payments

  • Payment